Notably, the expression of ERK1 in DIPG was further elevated in the presence of iPSC-astrocytes, implying that interactions with iPSC-astrocytes enhance drug resistance and promote tumor survival in DIPG (Figure 5 and Figure 7A). The gene discussed is MAPK3; the disease is neoplasm.